The debate revealed that DNAJB6 evidence is limited to polyglutamine aggregation, with no direct testing of heterologous cross-seeding inhibition. This fundamental gap undermines the universal inhibitor hypothesis and requires specific cross-seeding assays. Source: Debate session sess_SDA-2026-04-01-gap-9137255b (Analysis: SDA-2026-04-01-gap-9137255b)
Landscape Summary: Does DNAJB6 directly inhibit cross-seeding between tau, α-synuclein, and TDP-43 or only homologous aggregation? is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
Does DNAJB6 directly inhibit cross-seeding between tau, α-synuclein, and TDP-43 or only homologous aggregation? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: